We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OVATF market cap is 1.36M. The company's latest EPS is CAD -0.0234 and P/E is -1.71.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 96k | 302k | 750k | 225k | 138k |
| Operating Income | -159k | -334k | -440k | -1.91M | -247k |
| Net Income | -508k | -835k | -1.18M | -2.39M | -794k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.73M | 1.84M | 3.25M | 769k | 105k |
| Total Liabilities | 536k | 362k | 143k | 63k | 188k |
| Total Equity | 2.19M | 1.48M | 3.11M | 706k | -83k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -383k | -952k | -1.39M | -886k | -670k |
| Investing | -1.5M | 895k | -685k | 1.16M | N/A |
| Financing | 2.06M | -29k | 2.05M | N/A | 47k |
| Market Cap | 1.36M |
| Price to Earnings Ratio | -1.71 |
| Price to Sales Ratio | 9.76 |
| Price to Cash Ratio | 44.44 |
| Price to Book Ratio | -16.33 |
| Dividend Yield | - |
| Shares Outstanding | 33.89M |
| Average Volume (1 week) | 8.5k |
| Average Volume (1 Month) | 6.13k |
| 52 Week Change | 253.98% |
| 52 Week High | 0.119177 |
| 52 Week Low | 0.0025 |
| Spread (Intraday) | 0.03 (52.15%) |
| Company Name | Ovation Science Inc (QB) |
| Address |
suite 704, 595 howe street vancouver, british columbia V6C 2T5 |
| Website | https://www.ovationscience.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
